Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Barriers of Visceral Leishmaniasis reporting and surveillance in Nepal: comparison of governmental VL-program districts with non-program districts.

Lim D, Banjara MR, Singh VK, Joshi AB, Gurung CK, Das ML, Matlashewski G, Olliaro P, Kroeger A.

Trop Med Int Health. 2019 Feb;24(2):192-204. doi: 10.1111/tmi.13189. Epub 2018 Dec 18.

PMID:
30565348
2.

Diminished responses to monoaminergic antidepressants but not ketamine in a mouse model for neuropsychiatric lupus.

Srikumar BN, Naidu PS, Kalidindi N, Paschapur M, Adepu B, Subramani S, Nagar J, Srivastava R, Sreedhara MV, Prasad DS, Das ML, Louis JV, Kuchibhotla VK, Dudhgaonkar S, Pieschl RL, Li YW, Bristow LJ, Ramarao M, Vikramadithyan RK.

J Psychopharmacol. 2019 Jan;33(1):25-36. doi: 10.1177/0269881118812102. Epub 2018 Nov 28.

PMID:
30484737
3.

Integrating Case Detection of Visceral Leishmaniasis and Other Febrile Illness with Vector Control in the Post-Elimination Phase in Nepal.

Banjara MR, Das ML, Gurung CK, Singh VK, Joshi AB, Matlashewski G, Kroeger A, Olliaro P.

Am J Trop Med Hyg. 2019 Jan;100(1):108-114. doi: 10.4269/ajtmh.18-0307.

4.

Susceptibility of field-collected Phlebotomus argentipes (Diptera: Psychodidae) sand flies from Bangladesh and Nepal to different insecticides.

Chowdhury R, Das ML, Chowdhury V, Roy L, Faria S, Priyanka J, Akter S, Maheswary NP, Khan RK, Argaw D, Kroeger A.

Parasit Vectors. 2018 Jun 4;11(1):336. doi: 10.1186/s13071-018-2913-6.

5.

Characterization of the adrenocorticotrophic hormone - induced mouse model of resistance to antidepressant drug treatment.

Srikumar BN, Paschapur M, Kalidindi N, Adepu B, Das ML, Sreedhara MV, Kuchibhotla VK, Pieschl RL, Li YW, Ega DSP, Louis JV, Murugesan S, Naidu PS, Ramarao M, Bristow LJ, Vikramadithyan RK.

Pharmacol Biochem Behav. 2017 Oct;161:53-61. doi: 10.1016/j.pbb.2017.09.003. Epub 2017 Sep 11.

PMID:
28911960
6.

Entomological efficacy of durable wall lining with reduced wall surface coverage for strengthening visceral leishmaniasis vector control in Bangladesh, India and Nepal.

Huda MM, Kumar V, Das ML, Ghosh D, Priyanka J, Das P, Alim A, Matlashewski G, Kroeger A, Alfonso-Sierra E, Mondal D.

BMC Infect Dis. 2016 Oct 6;16(1):539.

7.

Efficacy, Safety and Cost of Insecticide Treated Wall Lining, Insecticide Treated Bed Nets and Indoor Wall Wash with Lime for Visceral Leishmaniasis Vector Control in the Indian Sub-continent: A Multi-country Cluster Randomized Controlled Trial.

Mondal D, Das ML, Kumar V, Huda MM, Das P, Ghosh D, Priyanka J, Matlashewski G, Kroeger A, Upfill-Brown A, Chowdhury R.

PLoS Negl Trop Dis. 2016 Aug 17;10(8):e0004932. doi: 10.1371/journal.pntd.0004932. eCollection 2016 Aug.

8.

Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain.

Kostich W, Hamman BD, Li YW, Naidu S, Dandapani K, Feng J, Easton A, Bourin C, Baker K, Allen J, Savelieva K, Louis JV, Dokania M, Elavazhagan S, Vattikundala P, Sharma V, Das ML, Shankar G, Kumar A, Holenarsipur VK, Gulianello M, Molski T, Brown JM, Lewis M, Huang Y, Lu Y, Pieschl R, O'Malley K, Lippy J, Nouraldeen A, Lanthorn TH, Ye G, Wilson A, Balakrishnan A, Denton R, Grace JE, Lentz KA, Santone KS, Bi Y, Main A, Swaffield J, Carson K, Mandlekar S, Vikramadithyan RK, Nara SJ, Dzierba C, Bronson J, Macor JE, Zaczek R, Westphal R, Kiss L, Bristow L, Conway CM, Zambrowicz B, Albright CF.

J Pharmacol Exp Ther. 2016 Sep;358(3):371-86. doi: 10.1124/jpet.116.235333. Epub 2016 Jul 13.

9.

Implication of vector characteristics of Phlebotomus argentipes in the kala-azar elimination programme in the Indian sub-continent.

Chowdhury R, Kumar V, Mondal D, Das ML, Das P, Dash AP, Kroeger A.

Pathog Glob Health. 2016 May;110(3):87-96. doi: 10.1080/20477724.2016.1180775. Review.

10.

Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts.

Ostyn B, Uranw S, Bhattarai NR, Das ML, Rai K, Tersago K, Pokhrel Y, Durnez L, Marasini B, Van der Auwera G, Dujardin JC, Coosemans M, Argaw D, Boelaert M, Rijal S.

PLoS Negl Trop Dis. 2015 Aug 7;9(8):e0003966. doi: 10.1371/journal.pntd.0003966. eCollection 2015.

11.

Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.

Banjara MR, Kroeger A, Huda MM, Kumar V, Gurung CK, Das ML, Rijal S, Das P, Mondal D.

Trans R Soc Trop Med Hyg. 2015 Jun;109(6):408-15. doi: 10.1093/trstmh/trv031. Epub 2015 Apr 26.

12.

Long-lasting insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent; methodological lessons learned from a cluster randomised controlled trial.

Picado A, Ostyn B, Rijal S, Sundar S, Singh SP, Chappuis F, Das ML, Khanal B, Gidwani K, Hasker E, Dujardin JC, Vanlerberghe V, Menten J, Coosemans M, Boelaert M.

PLoS Negl Trop Dis. 2015 Apr 9;9(4):e0003597. doi: 10.1371/journal.pntd.0003597. eCollection 2015 Apr. No abstract available.

13.

Do Size and Insecticide Treatment Matter? Evaluation of Different Nets against Phlebotomus argentipes, the Vector of Visceral Leishmaniasis in Nepal.

Das ML, Rowland M, Austin JW, De Lazzari E, Picado A.

PLoS One. 2014 Dec 10;9(12):e114915. doi: 10.1371/journal.pone.0114915. eCollection 2014.

14.

Research priorities for elimination of visceral leishmaniasis.

Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P.

Lancet Glob Health. 2014 Dec;2(12):e683-4. doi: 10.1016/S2214-109X(14)70318-3. No abstract available.

15.

Exposure to Phlebotomus argentipes (Diptera, Psychodidae, Phlebotominae) sand flies in rural areas of Bihar, India: the role of housing conditions.

Malaviya P, Hasker E, Picado A, Mishra M, Van Geertruyden JP, Das ML, Boelaert M, Sundar S.

PLoS One. 2014 Sep 3;9(9):e106771. doi: 10.1371/journal.pone.0106771. eCollection 2014.

16.

Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice.

Vijaya Kumar K, Rudra A, Sreedhara MV, Siva Subramani T, Prasad DS, Das ML, Murugesan S, Yadav R, Trivedi RK, Louis JV, Li YW, Bristow LJ, Naidu PS, Vikramadithyan RK.

Brain Behav Immun. 2014 Nov;42:204-11. doi: 10.1016/j.bbi.2014.06.205. Epub 2014 Jul 9.

PMID:
25016199
17.

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance.

Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC.

Clin Infect Dis. 2013 Jun;56(11):1530-8. doi: 10.1093/cid/cit102. Epub 2013 Feb 20.

PMID:
23425958
18.

An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani.

Uranw S, Hasker E, Roy L, Meheus F, Das ML, Bhattarai NR, Rijal S, Boelaert M.

BMC Infect Dis. 2013 Jan 18;13:21. doi: 10.1186/1471-2334-13-21.

19.
20.

Malarial nephropathy in a tertiary care setup--an observational study.

Sharma SK, Manandhar DN, Khanal B, Dhakal S, Kalra S, Das ML, Karki P.

Nepal Med Coll J. 2011 Jun;13(2):123-7.

PMID:
22364097
21.

Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal.

Picado A, Singh SP, Vanlerberghe V, Uranw S, Ostyn B, Kaur H, Das ML, Sundar S, Rijal S, Tungu P, Boelaert M, Rowland M.

Trans R Soc Trop Med Hyg. 2012 Mar;106(3):150-9. doi: 10.1016/j.trstmh.2011.10.014. Epub 2011 Dec 2.

PMID:
22137191
22.

Toolkit for monitoring and evaluation of indoor residual spraying for visceral leishmaniasis control in the Indian subcontinent: application and results.

Huda MM, Mondal D, Kumar V, Das P, Sharma SN, Das ML, Roy L, Gurung CK, Banjara MR, Akhter S, Maheswary NP, Kroeger A, Chowdhury R.

J Trop Med. 2011;2011:876742. doi: 10.1155/2011/876742. Epub 2011 Jul 27.

23.

The Indian and Nepalese programmes of indoor residual spraying for the elimination of visceral leishmaniasis: performance and effectiveness.

Chowdhury R, Huda MM, Kumar V, Das P, Joshi AB, Banjara MR, Akhter S, Kroeger A, Krishnakumari B, Petzold M, Mondal D, Das ML.

Ann Trop Med Parasitol. 2011 Jan;105(1):31-5. doi: 10.1179/136485911X12899838683124.

24.

Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial.

Picado A, Singh SP, Rijal S, Sundar S, Ostyn B, Chappuis F, Uranw S, Gidwani K, Khanal B, Rai M, Paudel IS, Das ML, Kumar R, Srivastava P, Dujardin JC, Vanlerberghe V, Andersen EW, Davies CR, Boelaert M.

BMJ. 2010 Dec 29;341:c6760. doi: 10.1136/bmj.c6760.

25.

Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal.

Dinesh DS, Das ML, Picado A, Roy L, Rijal S, Singh SP, Das P, Boelaert M, Coosemans M.

PLoS Negl Trop Dis. 2010 Oct 26;4(10):e859. doi: 10.1371/journal.pntd.0000859.

26.

Insecticide-treated bed nets in rural Bangladesh: their potential role in the visceral leishmaniasis elimination programme.

Mondal D, Chowdhury R, Huda MM, Maheswary NP, Akther S, Petzold M, Kumar V, Das ML, Gurung CK, Ghosh D, Kroeger A.

Trop Med Int Health. 2010 Nov;15(11):1382-9. doi: 10.1111/j.1365-3156.2010.02635.x. Epub 2010 Oct 13.

27.

Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal.

Rijal S, Uranw S, Chappuis F, Picado A, Khanal B, Paudel IS, Andersen EW, Meheus F, Ostyn B, Das ML, Davies C, Boelaert M.

Trop Med Int Health. 2010 Jul;15 Suppl 2:21-8. doi: 10.1111/j.1365-3156.2010.02518.x. Epub 2010 May 6.

28.

Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal.

Khanal B, Picado A, Bhattarai NR, Van Der Auwera G, Das ML, Ostyn B, Davies CR, Boelaert M, Dujardin JC, Rijal S.

Parasitology. 2010 Sep;137(11):1597-603. doi: 10.1017/S0031182010000521. Epub 2010 May 12.

29.

Phlebotomus argentipes seasonal patterns in India and Nepal.

Picado A, Das ML, Kumar V, Dinesh DS, Rijal S, Singh SP, Das P, Coosemans M, Boelaert M, Davies C.

J Med Entomol. 2010 Mar;47(2):283-6.

PMID:
20380311
30.

Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial.

Picado A, Das ML, Kumar V, Kesari S, Dinesh DS, Roy L, Rijal S, Das P, Rowland M, Sundar S, Coosemans M, Boelaert M, Davies CR.

PLoS Negl Trop Dis. 2010 Jan 26;4(1):e587. doi: 10.1371/journal.pntd.0000587.

31.

Domestic animals and epidemiology of visceral leishmaniasis, Nepal.

Bhattarai NR, Van der Auwera G, Rijal S, Picado A, Speybroeck N, Khanal B, De Doncker S, Das ML, Ostyn B, Davies C, Coosemans M, Berkvens D, Boelaert M, Dujardin JC.

Emerg Infect Dis. 2010 Feb;16(2):231-7. doi: 10.3201/eid1602.090623.

32.

Comparative study of kala-azar vector control measures in eastern Nepal.

Das ML, Roy L, Rijal S, Paudel IS, Picado A, Kroeger A, Petzold M, Davies C, Boelaert M.

Acta Trop. 2010 Feb;113(2):162-6. doi: 10.1016/j.actatropica.2009.10.012. Epub 2009 Oct 30.

PMID:
19879851
33.

Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal.

Joshi AB, Das ML, Akhter S, Chowdhury R, Mondal D, Kumar V, Das P, Kroeger A, Boelaert M, Petzold M.

BMC Med. 2009 Oct 5;7:54. doi: 10.1186/1741-7015-7-54.

34.

Natural infection of Phlebotomus argentipes with Leishmania and other trypanosomatids in a visceral leishmaniasis endemic region of Nepal.

Bhattarai NR, Das ML, Rijal S, van der Auwera G, Picado A, Khanal B, Roy L, Speybroeck N, Berkvens D, Davies CR, Coosemans M, Boelaert M, Dujardin JC.

Trans R Soc Trop Med Hyg. 2009 Nov;103(11):1087-92. doi: 10.1016/j.trstmh.2009.03.008. Epub 2009 Apr 3.

PMID:
19345387
35.

Population structure and geographical subdivision of the Leishmania major vector Phlebotomus papatasi as revealed by microsatellite variation.

Hamarsheh O, Presber W, Yaghoobi-Ershadi MR, Amro A, Al-Jawabreh A, Sawalha S, Al-Lahem A, Das ML, Guernaoui S, Seridi N, Dhiman RC, Hashiguchi Y, Ghrab J, Hassan M, Schönian G.

Med Vet Entomol. 2009 Mar;23(1):69-77. doi: 10.1111/j.1365-2915.2008.00784.x.

PMID:
19239616
36.

PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar.

Bhattarai NR, Van der Auwera G, Khanal B, De Doncker S, Rijal S, Das ML, Uranw S, Ostyn B, Praet N, Speybroeck N, Picado A, Davies C, Boelaert M, Dujardin JC.

Trop Med Int Health. 2009 Apr;14(4):404-11. doi: 10.1111/j.1365-3156.2009.02242.x. Epub 2009 Feb 17.

37.

Population preference of net texture prior to bed net trial in Kala-Azar-endemic areas.

Das ML, Singh SP, Vanlerberghe V, Rijal S, Rai M, Karki P, Sundar S, Boelaert M.

PLoS Negl Trop Dis. 2007 Dec 12;1(3):e100.

38.

Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.

Das ML, Deb M, Karki BM, Sarif M, Khanal B, Bhattacharya SK, Agrawal S, Koirala S.

Southeast Asian J Trop Med Public Health. 2007 Jul;38(4):619-25.

PMID:
17882997
39.

Prevalence of Shigella species and their antimicrobial resistance patterns in Eastern Nepal.

Bhattacharya S, Khanal B, Bhattarai NR, Das ML.

J Health Popul Nutr. 2005 Dec;23(4):339-42.

PMID:
16599104
40.

Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline.

Rijal S, Chappuis F, Singh R, Bovier PA, Acharya P, Karki BM, Das ML, Desjeux P, Loutan L, Koirala S.

Trans R Soc Trop Med Hyg. 2003 May-Jun;97(3):350-4.

PMID:
15228258
41.

Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.

Koirala S, Karki P, Das ML, Parija SC, Karki BM.

Trop Med Int Health. 2004 Apr;9(4):533-7.

42.

Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.

Karki P, Koirala S, Parija SC, Sethi M, Das ML.

Indian J Pathol Microbiol. 2003 Apr;46(2):214-5.

PMID:
15022913
43.

Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.

Karki P, Koirala S, Parija SC, Sethi M, Das ML.

Southeast Asian J Trop Med Public Health. 2003 Mar;34(1):22-3.

PMID:
12971510
44.

Prospective evaluation and comparison of the direct agglutination test and an rK39-antigen-based dipstick test for the diagnosis of suspected kala-azar in Nepal.

Chappuis F, Rijal S, Singh R, Acharya P, Karki BM, Das ML, Bovier PA, Desjeux P, Le Ray D, Koirala S, Loutan L.

Trop Med Int Health. 2003 Mar;8(3):277-85.

45.

Lymphatic leishmaniasis--first case report from Nepal.

Sharma SK, Das ML, Rijal S, Sah SP, Koirala S.

Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):749-50.

PMID:
12041549
46.

Post-kala-azar dermal leishmaniasis in Nepal.

Garg VK, Agrawal S, Rani S, Joshi A, Agarwalla A, Das ML, Koirala S.

Int J Dermatol. 2001 Mar;40(3):179-84.

PMID:
11422520
47.

Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective.

Bern C, Joshi AB, Jha SN, Das ML, Hightower A, Thakur GD, Bista MB.

Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):184-8.

PMID:
11388512
48.

Knowledge, attitudes, and practices about kala-azar and its sandfly vector in rural communities of Nepal.

Koirala S, Parija SC, Karki P, Das ML.

Bull World Health Organ. 1998;76(5):485-90.

49.

A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.

Karki P, Koirala S, Parija SC, Hansdak SG, Das ML.

Southeast Asian J Trop Med Public Health. 1998 Mar;29(1):154-8.

PMID:
9740292
50.

Visceral leishmaniasis with cutaneous ulcer or cutaneous leishmaniasis in Nepal.

Karki P, Parija SC, George S, Das ML, Koirala S.

Southeast Asian J Trop Med Public Health. 1997 Dec;28(4):836-7. No abstract available.

PMID:
9656411

Supplemental Content

Support Center